Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign In
or
Register
to read more
16983
Related Questions
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you use serum IgG levels when treating with FcRN inhibitors?
Do you always stop dexamethasone at discharge for patients admitted with COVID requiring respiratory support (as done in the RECOVERY trial), or are there situations in which you will prescribe it to complete a 10-day course?
Which methods of tracking response to treatment in myasthenia gravis do you find most helpful?
How long do you treat Staphylococcus aureus pyomyositis with antibiotics?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
How do you decide when to add steroid-sparing immunotherapy for myasthenia gravis after starting prednisone and Mestinon?